CAMP4 Therapeutics (CAMP) Stock Analysis
NASDAQHealthcareBiotechnology
What CAMP4 Therapeutics does
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Key metrics
ETFs linked to CAMP
Broad-market and Healthcare sector ETFs an investor holding CAMP4 Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how CAMP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze CAMP in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for CAMP4 Therapeutics?
- CAMP4 Therapeutics trades under the ticker CAMP on NASDAQ.
- Which exchange is CAMP listed on?
- CAMP is listed on NASDAQ.
- What sector does CAMP4 Therapeutics operate in?
- CAMP4 Therapeutics is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze CAMP in a portfolio?
- PortView shows CAMP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.